Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Effects and noneffects of methylphenidate in children with mental retardation and ADHD.

Handen BL, Breaux AM, Janosky J, McAuliffe S, Feldman H, Gosling A.

J Am Acad Child Adolesc Psychiatry. 1992 May;31(3):455-61.

PMID:
1592777
2.

Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.

Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman H.

Pediatrics. 1990 Dec;86(6):922-30.

PMID:
2135682
3.

Prediction of response to methylphenidate among children with ADHD and mental retardation.

Handen BL, Janosky J, McAuliffe S, Breaux AM, Feldman H.

J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1185-93.

PMID:
7982869
4.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
5.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
6.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
7.

Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.

Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, Faria LP, Mansour R, Henderson JA, Payne CD, Roache JD, Lachar D, Cleveland LA.

J Am Acad Child Adolesc Psychiatry. 2004 Jun;43(6):686-98.

PMID:
15167085
8.

Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.

Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA.

J Am Acad Child Adolesc Psychiatry. 2004 Jun;43(6):677-85.

PMID:
15167084
9.

Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.

Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA.

J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):209-16.

PMID:
12544181
10.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
11.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
13.

Adverse side effects of methylphenidate among mentally retarded children with ADHD.

Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S.

J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):241-5.

PMID:
2016228
14.

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

Tannock R, Ickowicz A, Schachar R.

J Am Acad Child Adolesc Psychiatry. 1995 Jul;34(7):886-96.

PMID:
7649959
15.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
16.

Methylphenidate dosing: twice daily versus three times daily.

Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ.

Pediatrics. 1996 Oct;98(4 Pt 1):748-56.

PMID:
8885956
17.

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

Handen BL, Feldman HM, Lurier A, Murray PJ.

J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):805-12.

PMID:
10405497
18.

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.

Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL.

Pediatrics. 1999 Dec;104(6):1300-11.

PMID:
10585981
19.

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Findling RL, Swanson JM; ADHD Study Group.

Pediatrics. 2002 Mar;109(3):E39.

PMID:
11875167
20.

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

Aman MG, Kern RA, McGhee DE, Arnold LE.

J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):851-9.

PMID:
8340309

Supplemental Content

Support Center